FDA to Consider OraSure OTC HIV Test for US Sales
The FDA BPAC will consider the OraSure’s application for the approval of its OraQuick Rapid HIV-1/2 test for sale in the US consumer or OTC market at a meeting scheduled for May 15, 2012.
Read MoreSearch Results for: point-of-care testing
One Control Does Not Fit All
The future of quality control design
Read More
POC Coagulation Testing Taking a Bite Out of the Market
Acceptance of point-of-care testing grows as the tests’ performance improves
Read More
Misc Supplies
Current Technologies Inc
Read More
To the Point
Acceptance of point-of-care testing grows as the tests’ performance improves.
Read More